Aughton, Karen 
ORCID: 0000-0002-5184-5789, Sabat-Pospiech, Dorota, Barlow, Samantha, Coupland, Sarah E ORCID: 0000-0002-1464-2069 and Kalirai, Helen ORCID: 0000-0002-4440-2576
(2022)
Investigating the Role of DUSP4 in Uveal Melanoma.
Translational vision science & technology, 11 (12).
p. 13.
Abstract
<h4>Purpose</h4>Dual-specificity phosphatase 4 (DUSP4) inactivates factors in the mitogen-activated protein kinase (MAPK) signaling cascade, activated in uveal melanoma (UM) by mutations in upstream G-protein α subunits GNAQ/11 in >90% cases. This study examined whether DUSP4 (1) protein expression in primary UM (pUM) was a biomarker of metastatic risk and (2) knockdown sensitized UM cells to therapeutic agents, selumetinib or doxorubicin.<h4>Methods</h4>DUSP4 mRNA data from The Cancer Genome Atlas and DUSP4 protein expression examined using immunohistochemistry in 28 cases of pUM were evaluated for association with clinical, genetic, and histological features. In vitro cytotoxic drug assays tested the efficacy of selumetinib and doxorubicin in UM cell lines with/without small interfering RNA DUSP4 gene silencing.<h4>Results</h4>DUSP4 protein expression was observed in 93% of cases, with strong nuclear positivity in 79%. Despite higher DUSP4 messenger RNA levels in disomy 3/wild-type BAP1 UM, there was no significant association of nDUSP4 protein with these metastatic risk predictors or outcome. DUSP4 expression in UM cell lines varied. DUSP4 silencing in Mel202, MP46, and MP41 cells did not affect ERK1/2 or phospho-ERK levels. Despite increased phospho-ERK levels in Mel285, no cell line showed enhanced sensitivity to selumetinib/doxorubicin.<h4>Conclusions</h4>DUSP4 protein expression is not a biomarker of UM metastatic risk. DUSP4 plays a complex role in oncogenesis, as reported in other cancers, and further work is required to fully understand its functional role in the MAPK pathway.<h4>Translational relevance</h4>Understanding the role of phosphatases, such as DUSP4, in the control of intracellular signaling cascades will facilitate our ability to identify successful treatment options.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | uveal melanoma, metastasis, DUSP4, immunohistochemistry, siRNA, doxorubicin, selumetinib, BAP1 |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 18 Jan 2023 11:35 |
| Last Modified: | 14 Mar 2024 18:45 |
| DOI: | 10.1167/tvst.11.12.13 |
| Open Access URL: | https://doi.org/10.1167/tvst.11.12.13 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3167120 |
Dimensions
Dimensions
